Nrf2 in Neoplastic and Non-Neoplastic Liver Diseases
Overview
Affiliations
Activation of the Keap1/Nrf2 pathway, the most important cell defense signal, triggered to neutralize the harmful effects of electrophilic and oxidative stress, plays a crucial role in cell survival. Therefore, its ability to attenuate acute and chronic liver damage, where oxidative stress represents the key player, is not surprising. On the other hand, while Nrf2 promotes proliferation in cancer cells, its role in non-neoplastic hepatocytes is a matter of debate. Another topic of uncertainty concerns the nature of the mechanisms of Nrf2 activation in hepatocarcinogenesis. Indeed, it remains unclear what is the main mechanism behind the sustained activation of the Keap1/Nrf2 pathway in hepatocarcinogenesis. This raises doubts about the best strategies to therapeutically target this pathway. In this review, we will analyze and discuss our present knowledge concerning the role of Nrf2 in hepatic physiology and pathology, including hepatocellular carcinoma. In particular, we will critically examine and discuss some findings originating from animal models that raise questions that still need to be adequately answered.
Catechins: Protective mechanism of antioxidant stress in atherosclerosis.
Sheng Y, Sun Y, Tang Y, Yu Y, Wang J, Zheng F Front Pharmacol. 2023; 14:1144878.
PMID: 37033663 PMC: 10080012. DOI: 10.3389/fphar.2023.1144878.
Khan M, Boufaied N, Yeganeh M, Kandhi R, Petkiewicz S, Sharma A Cancers (Basel). 2023; 15(3).
PMID: 36765862 PMC: 9913612. DOI: 10.3390/cancers15030905.
Novel NRF2-activated cancer treatments utilizing synthetic lethality.
Baird L, Kensler T, Yamamoto M IUBMB Life. 2022; 74(12):1209-1231.
PMID: 36200139 PMC: 10092255. DOI: 10.1002/iub.2680.
p62 Promotes Survival and Hepatocarcinogenesis in Mice with Liver-Specific NEMO Ablation.
Kondylis V, Schneider F, Schorn F, Oikonomou N, Straub B, Werner S Cancers (Basel). 2022; 14(10).
PMID: 35626041 PMC: 9139637. DOI: 10.3390/cancers14102436.
Selvaggi F, Catalano T, Cotellese R, Aceto G Cancers (Basel). 2022; 14(8).
PMID: 35454818 PMC: 9024538. DOI: 10.3390/cancers14081912.